At an Oct. 12 H1 2026 results briefing, Hebang Bio said H2 production and sales
of phosphate ore are operating normally and it currently sees no risk of large
swings in selling prices or gross margins. The company said glyphosate sector
supply/demand and prices are driven by multiple factors; both of its glyphosate
production lines are running at full capacity. Hebang is prioritizing inventory
reduction and cash generation this year and will adjust shipment volumes based
on market forecasts. El Niño and other climate phenomena add uncertainty to
global agricultural activity and herbicide demand.